Oral and IV Cladribine

A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1
Enrollment
40 patients (estimated)
Sponsors
MD Anderson Cancer Center
Trial Type
Treatment
Last Update
2 months ago
SparkCures ID
1833
NCT Identifier
NCT06021600

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.